Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03181308
Title Study of Carotuximab (TRC105) Plus Nivolumab in Patients With Metastatic NSCLC
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Tracon Pharmaceuticals Inc.
Indications

lung non-small cell carcinoma

Therapies

Carotuximab + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST